课题基金 / 基金详情

IL-1B regulation of Zika-Mediated adverse perinatal outcomes

IL-1B regulation of Zika-Mediated adverse perinatal outcomes
IL-1B 对寨卡介导的不良围产期结局的调节
批准号:
10782381
负责人:
IRINA BURD
金额:
$32.05万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-03-10 至 2024-06-30

项目摘要

项目成果

IRINA BURD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SUMMARY Zika virus (ZIKV) infection of pregnant females results in congenital infection of offspring and long-term developmental birth defects. Using an immunocompetent mouse model that we developed (published in Nature Communications), we have shown that intrauterine infection with either African, American, or Asian strains of ZIKV during early, but not late, pregnancy causes infection of the placenta and fetuses, placental inflammation, neonatal cortical thinning, and short-term neurologic deficits in offspring. More recently, we have demonstrated that placental IL-1β concentrations are elevated in ZIKV-infected dams, and we can reverse the ZIKV-associated short-term neurobehavioral sequelae in offspring by blocking IL-1 receptor signaling during the infection. We hypothesize that placental inflammation following intrauterine ZIKV infection causes perinatal neurological injury, which can then be reversed by targeting maternal IL-1β signaling. While most ZIKV interventions focus on antivirals and vaccines to limit perinatal ZIKV infection, to date no studies have considered the role of maternal and placental inflammation as a mechanism mediating long-term adverse perinatal outcomes following ZIKV infection. Specific Aim 1 will assess the mechanisms mediating elevated IL- 1β signaling in the placenta at different gestational ages following ZIKV infection, the long-term downstream effects of the placental immunopathology and placental IL-1β signaling, and whether these effects are sex- specific. In particular, Aim 1 will determine how placental inflammasome activation, IL-1β release, or engagement of the IL-1 receptor lead to adverse perinatal outcomes. Specific Aim 2 will examine the importance of maternal as opposed to fetal IL-1β signaling in the pathogenesis of perinatal brain injury following ZIKV infection. Using embryo transfer of IL-1β signaling deficient and wild type mouse strains, Aim 2 will assess whether IL-1β activity of maternal origin is critical for sex-specific fetal brain injury. Our novel translational research proposal, utilizing a ZIKV model that we developed, will have a significant impact on perinatal medicine as it will lead to a better understanding of the role of placental inflammation in the pathogenesis of fetal congenital diseases caused by infection or other inflammatory states during pregnancy.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.vaccine.2022.10.003
发表时间: 2022-11-08
期刊: VACCINE
影响因子: 5.5
作者: [Creisher, Patrick S, Campbell, Ariana D, Perry, Jamie L, Roznik, Katerina, Burd, Irina, Klein, Sabra L]
通讯作者: Klein, Sabra L
DOI: 10.1111/aji.13248
发表时间: 2020-07
期刊: American journal of reproductive immunology (New York, N.Y. : 1989)
影响因子: --
作者: [Chudnovets A, Lei J, Na Q, Dong J, Narasimhan H, Klein SL, Burd I]
通讯作者: Burd I
Placental Serum Amyloid A as a Therapeutic Target to Prevent Preterm Birth and Prematurity Related Morbidity
Nanomedicine-based approach for characterizing the epigenome in prevention of inflammation-induced preterm birth.
  • 批准号:
    10586624
  • 项目类别:
  • 资助金额:
    $62.44万
  • 财政年份:
    2022
  • 负责人:
    IRINA BURD
  • 依托单位:
Nanomedicine approaches for prevention of inflammation-induced preterm birth
  • 批准号:
    10392489
  • 项目类别:
  • 资助金额:
    $62.97万
  • 财政年份:
    2021
  • 负责人:
    IRINA BURD
  • 依托单位:
7/24 Healthy Brain and Child Development National Consortium
  • 批准号:
    10380210
  • 项目类别:
  • 资助金额:
    $96.91万
  • 财政年份:
    2021
  • 负责人:
    IRINA BURD
  • 依托单位:
国内基金
海外基金
冰融水脉冲1b的时间、来源及成因机制 研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    高雅
  • 依托单位:
基于α1B受体介导p38/NFAT2信号通路研究多肽ACTY116改善高血压 性心肌肥厚的作用机制
KLF5-CHAF1A/1B轴调控早期食管癌的功能和机制研究
  • 批准号:
    2024Y9378
  • 项目类别:
    省市级项目
  • 资助金额:
    45.0万元
  • 批准年份:
    2024
  • 负责人:
    李彩苹
  • 依托单位:
含DEP结构域蛋白1B通过β-catenin/TCF4信号通路参与多形性胶质母细胞瘤发生发展机制的探究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2022
  • 负责人:
  • 依托单位: